HCA: financial statements from SEC

Income statement

Metric	Dec 31, 2025	Dec 31, 2024
Revenue	75.60bn	70.60bn
Operating expenses	65.77bn	62.08bn
Interest expense	2.25bn	2.06bn
Pre-tax income	9.83bn	8.52bn
Income tax	2.05bn	1.87bn
Net income	6.78bn	5.76bn
Earnings per share	28.70	22.27
Earnings per share, diluted	28.33	22.00
Weighted average shares	236m	259m
Weighted average shares, diluted	239m	262m

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	940m	1.04bn	997m	939m	1.06bn	1.93bn	2.89bn	831m
Receivables	11.32bn	10.87bn	10.43bn	10.46bn	11.09bn	10.75bn	9.92bn	10.24bn
Inventory	1.68bn	1.65bn	1.73bn	1.79bn	1.79bn	1.74bn	1.78bn	1.80bn
Current assets	16.05bn	15.78bn	15.29bn	15.56bn	16.26bn	16.41bn	16.66bn	15.17bn
Property, plant and equipment	31.47bn	31.14bn	30.57bn	30.12bn	29.74bn	29.41bn	29.05bn	28.64bn
Total assets	61.45bn	60.72bn	59.75bn	59.54bn	59.80bn	59.51bn	59.46bn	57.38bn
Current liabilities	19.26bn	16.35bn	17.90bn	15.94bn	13.63bn	15.18bn	14.90bn	14.30bn
Short-term debt	8.53bn	4.89bn	6.11bn	5.10bn	3.52bn	4.70bn	4.68bn	4.57bn
Long-term debt	39.49bn	41.60bn	38.40bn	39.38bn	41.06bn	38.33bn	38.28bn	36.31bn
Equity	−6.30bn	−6.03bn	−5.34bn	−1.24bn	−438m	−2.50bn	786m	1.34bn
Shares outstanding	223m	225m	230m	236m	243m	250m	255m	259m

Metric	Dec 31, 2025	Dec 31, 2024
Operating cash flow	12.64bn	10.51bn
Depreciation and amortisation	3.52bn	3.31bn
Share-based compensation	401m	360m
Capital expenditure	4.94bn	4.88bn
Investing cash flow	−4.99bn	−4.93bn
Dividends paid	679m	690m
Share buybacks	10.07bn	6.04bn
Financing cash flow	−8.55bn	−4.58bn